Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037632 · ClinicalTrials.gov registry record · NA
DCM Precision Medicine Study
A NA study of Idiopathic Dilated Cardiomyopathy, sponsored by Ray Hershberger.
- Active
- Registry status
- NA
- Development phase
- 6,500
- Enrollment target
- 20
- Study locations
NCT03037632: Active NA study of Idiopathic Dilated Cardiomyopathy, sponsored by Ray Hershberger.
NCT03037632 is a NA study of Idiopathic Dilated Cardiomyopathy that is active but no longer recruiting, run by Ray Hershberger. The registered enrollment target is 6,500 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (363% higher). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03037632, a NA study of Idiopathic Dilated Cardiomyopathy, is active but no longer recruiting, sponsored by Ray Hershberger.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The aims of the DCM Precision Medicine Study are to test the hypothesis that DCM has substantial genetic basis and to evaluate the effectiveness of a family communication intervention in improving the uptake and impact of family member clinical screening.
Primary Outcome
The probability that a living first-degree relative (FDR) without a previous definitive DCM diagnosis completes clinical screening for DCM within 12 months after proband recruitment
Conditions Studied
Interventions
- BEHAVIORAL Family Heart Talk Booklet
Study Locations (20)
California
- Cedars-Sinai Medical Center - Beverly Hills
- UCLA Medical Center - Los Angeles
- Stanford University - Palo Alto
Ohio
- Cleveland Clinic - Cleveland
- Ohio State University - Columbus
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- University of Arizona Sarver Heart Center - Tucson
District of Columbia
- Medstar Washington Hospital Center (DC) - Washington D.C.
Florida
- South Miami Heart Center - Miami
Georgia
- Emory University - Atlanta
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,500 participants |
| Start Date | 2016-06-07 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT03037632 still lists
NCT03037632 is an interventional study that assigns participants to a tested intervention. Its 6,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (363% higher).
The record links to 1 condition, with Idiopathic Dilated Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which Family Heart Talk Booklet is the first listed.
NCT03037632 names 20 study sites across 17 states, led by California, Ohio, Alabama.
Frequently Asked Questions
What is clinical trial NCT03037632 about?
NCT03037632 is a clinical study titled "DCM Precision Medicine Study". The aims of the DCM Precision Medicine Study are to test the hypothesis that DCM has substantial genetic basis and to evaluate the effectiveness of a family communication intervention in improving the uptake and impact of family member clinical screening.
What is the current status of trial NCT03037632?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6,500 participants. The study started on 2016-06-07. Estimated completion is 2026-06-30.
What conditions does trial NCT03037632 study?
This clinical trial studies the following conditions: Idiopathic Dilated Cardiomyopathy.
What interventions are being tested in trial NCT03037632?
The interventions under investigation include: Family Heart Talk Booklet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03037632?
This trial is sponsored by Ray Hershberger, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03037632 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03037632's enrollment target sits among peer trials
6,500 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00505245 · 6,500 participants
New Assessment System in Measuring Symptom Distress in Cancer Patients
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI